FTC Backs Single 30-Month Stay On Generic Rx Approvals In Patent Litigation
Executive Summary
The Federal Trade Commission supports a limit of one 30-month stay of approval on generic drugs in patent litigation
You may also be interested in...
The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills
The Medicare drug benefit, created in 2003, is casting a long shadow on the health care reform debate of 2009
The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills
The Medicare drug benefit, created in 2003, is casting a long shadow on the health care reform debate of 2009
FTC’s Next Chairman Expected To Be Health Care Antitrust Expert Majoras
President Bush intends to nominate health care antitrust attorney Deborah Majoras as Federal Trade Commission chairman